Olivia Lara

7PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 29, 2026
Impact of Allostatic Load on Overall Survival in Patients With Endometrial Cancer.

|Mar 19, 2026
Immune-Related Adverse Events Among Patients With Endometrial Cancer Receiving Pembrolizumab Alone or With Other Treatments: A Single-Center Real-World Experience.

Glenn Boyles, Chelsey Vranes, Nikita Sinha

|Dec 19, 2024
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma.

Daniela E Matei, Danielle M Enserro, Marcus E Randall

|Sep 14, 2024
Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside.

Elif Çakan, Olivia D Lara, Anna Szymanowska

|Dec 09, 2020
Racial disparities in patients with coronavirus disease 2019 infection and gynecologic malignancy.

Olivia D Lara, Maria J Smith, Yuyan Wang

|Jul 31, 2020
COVID-19 outcomes of patients with gynecologic cancer in New York City.

Olivia D Lara, Roisin E O'Cearbhaill, Maria J Smith

Pageof 2

Frequent Collaborators

1 joint publications

Yuexin Liu

1 joint publications

Megan E Sutter

1 joint publications

Maria J Smith

1 joint publications

Anna Szymanowska